摘要
本文运用增殖细胞核抗原(PCNA)单克隆抗体对88例乳腺病变组织进行免疫组化研究,并与乳腺癌组织学分级和淋巴结转移作了对比分析,结果显示:乳腺良性病变阳性率为16%,乳腺癌为73.02%,两者比较有显著性差异P<0.01),pCNA指数与乳腺癌组织学分级淋巴结转移密切相关.作者认为PCNA的表达对区分良恶性病变及组织学分级,淋巴(?)转移(?)为客观可靠,是(?)癌预后判断的良好指标.
An immunochemical study on 88 cases of breast lesion with proliferating Cell nuclear antigen (PCNA) and monoclonal antibody was carried out and compared with his-tograding of breasrt carcinoma and analysis of lymphatic metastasis. The result indicates:the positive rate of benign breast lesion is 16% , breast carcinoma 73. 02% with a significant dif-ference (P<0.01). It revealed a close relationship between the PCNA index and the his-tograding of breast carcinoma, and lymphatic metastasis. The authors suggest that PCNA assessment is objective, dependable in differentiating benign breast lesion from the malignat lesion and histograding, lymphatic metastasis. It is an adoptable index for the prognosis of breast carcinoma
出处
《农垦医学》
1995年第2期75-77,共3页
Journal of Nongken Medicine
基金
兵团科研基金资助课题
关键词
增殖细胞核抗原
乳腺癌
预后
proliferating cell nuclear antigen (PCNA) breast carcinoma prognosis
